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Medication-overuse headache (MOH) is a chronic daily
headache evolving from an episodic primary headache
(mainly migraine) due to overuse of one or more classes
of migraine abortive medication.
The development of MOH is associated with both
overuse of one or more medication and behavioral
predispositions.
MOH causes a significant decline in the quality of life
and reduces functioning in patients affected. In the
same MOH patients, the presence of psychopathological
disturbances may be a predictor of relapse and poor
response to treatment.
In a recent study of our group, we found that MOH
patients had a more complex profile of psychiatric comor-
bidity compared to episodic migraine (EM) patients.
Furthermore, clinically relevant obsessive-compulsive dis-
turbances for abused drugs assessed by Yale-Brown
Obsessive Compulsive Scale Y-BOCS, appeared to be
more represented in the MOH group, while the prevalence
of this trait in the EM group was comparable to that of
healthy controls (unpublished results).
Management of MOH represents a difficult challenge
for clinicians and headache experts, particularly because of
the high percentage of relapse after a successful withdra-
wal treatment.
This can be addressed if the patient is followed over a
prolonged period of time with a combination of prophy-
lactic pharmacotherapy and use of abortive medication
with minimal risk of MOH, avoiding previously overused
medications.
With the aim to verify the efficacy and safety of
sodium valproate in the short-term treatment of MOH,
we recently carried out a multicentre study (SAMOHA
study) which demonstrated a superiority of the drug
compared to placebo after detoxification [1].
In an ancillary study of SAMOHA, analysing responders
and non responders to detoxification and advice to with-
draw a benefit was excluded in patients with a long history
of MOH [2].
In a further ancillary research we found a significant
correlation between MOH relapse and the total MSQ
score, the Role Preventive and the Emotional Function
sub-scales, suggesting a poorer quality of life in non
responders [3].
Recent evidence suggests an involvement of genetic fac-
tors in predisposition to medication overuse. In a recent
study of our group involving a subsample of MOH
patients enrolled in the SAMOHA study, we sequenced all
exons, intron/exon junctions and 3’-5’UTR regions of
HDAC3 gene which had been implicated in excessive
medication consumption in MOH patients. Univariate
analysis showed that the G allele of the exonic SNP
rs2530223 was significantly associated with the number
of acute medications/month used and with the number
of days/month in which acute medication were used
(unpublished results).
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